Skip to content

Clinical trials

Prostatic Hyperplasia trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Country / region: Taiwan Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20072
20091
20103
20121
20133
20141
20162
20172
20181
20191
20201
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Unknown status6
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Health Ever Bio-Tech Co., Ltd.3
GlaxoSmithKline2
National Cheng-Kung University Hospital2
Taipei Medical University WanFang Hospital2
Allergan1
Astellas Pharma Inc1
Astellas Pharma Taiwan, Inc.1
Buddhist Tzu Chi General Hospital1
Cheng-Hsin General Hospital1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia24
Lower Urinary Tract Symptoms8
Erectile Dysfunction2
Prostatic Neoplasms2
Urinary Bladder, Overactive1

Trials

Showing 51 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.